Search

everythinglearnresearchcommunity

for

Search:↓

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Acid inside cells speeds up aging and turns on aging signs in mice.

Re-evaluating minoxidil, reducing sodium intake, and addressing arteriolar hypertrophy can improve hypertension management.

New instruments were introduced to make hair transplantation surgery more precise and improve graft survival.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

CAR is a useful marker for assessing alopecia areata severity.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

The study found that the hair loss condition in Cesky Fousek dogs is influenced by multiple genes affecting skin and muscle structure, fat metabolism, and immunity.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Myo-inositol-based treatments greatly improve pregnancy chances for women with PCOS.

Netherton syndrome can cause severe dehydration, infections, and growth issues in infants.

Pinus densiflora extract may help improve memory and reduce brain inflammation.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

Tofacitinib is an effective and safe treatment for alopecia areata.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

New materials that better mimic natural skin structure could improve healing, especially for chronic wounds.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Skin changes are key for early diagnosis and treatment of rheumatic diseases.

Oral minoxidil is more convenient but topical minoxidil improves hair density better.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.